GB9420287D0 - 3-substituted heterocyclic indoles as inhibitors of HIV reverse transcriptase - Google Patents

3-substituted heterocyclic indoles as inhibitors of HIV reverse transcriptase

Info

Publication number
GB9420287D0
GB9420287D0 GB9420287A GB9420287A GB9420287D0 GB 9420287 D0 GB9420287 D0 GB 9420287D0 GB 9420287 A GB9420287 A GB 9420287A GB 9420287 A GB9420287 A GB 9420287A GB 9420287 D0 GB9420287 D0 GB 9420287D0
Authority
GB
United Kingdom
Prior art keywords
inhibitors
reverse transcriptase
substituted heterocyclic
hiv reverse
indoles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB9420287A
Other versions
GB2282808A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of GB9420287D0 publication Critical patent/GB9420287D0/en
Publication of GB2282808A publication Critical patent/GB2282808A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB9420287A 1993-10-14 1994-10-07 3-substituted heterocyclic indoles as inhibitors of HIV reverse transcriptase Withdrawn GB2282808A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13622493A 1993-10-14 1993-10-14

Publications (2)

Publication Number Publication Date
GB9420287D0 true GB9420287D0 (en) 1994-11-23
GB2282808A GB2282808A (en) 1995-04-19

Family

ID=22471909

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9420287A Withdrawn GB2282808A (en) 1993-10-14 1994-10-07 3-substituted heterocyclic indoles as inhibitors of HIV reverse transcriptase

Country Status (1)

Country Link
GB (1) GB2282808A (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
EP1771169A1 (en) 2004-07-14 2007-04-11 PTC Therapeutics, Inc. Methods for treating hepatitis c
US7868037B2 (en) 2004-07-14 2011-01-11 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7772271B2 (en) 2004-07-14 2010-08-10 Ptc Therapeutics, Inc. Methods for treating hepatitis C
NZ553329A (en) 2004-07-22 2010-09-30 Ptc Therapeutics Inc Thienopyridines for treating hepatitis C
CA2597447C (en) 2005-02-14 2014-03-25 Bionomics Limited Novel tubulin polymerisation inhibitors
KR102129658B1 (en) * 2015-02-12 2020-07-02 닛산 가가쿠 가부시키가이샤 Condensed heterocyclic compound and noxious organism control agent

Also Published As

Publication number Publication date
GB2282808A (en) 1995-04-19

Similar Documents

Publication Publication Date Title
FI956074A0 (en) 1-substituted isatin and oxidol derivatives as acetylcholinesterase inhibitors
PL331856A1 (en) Heterocyclic inhibitors of metaloprotease
AU641769B2 (en) Inhibitors of HIV reverse transcriptase
EP0519748A3 (en) Peptidyl derivatives as inhibitors of interleukin-1b converting enzyme
AU6178894A (en) Alkanesulfonamido-1-indanone derivatives as inhibitors of cyclooxygenase
AU2686588A (en) Heterocyclic derivatives of n-carbamoyl-, n-thiocarbamoyl- or n-amidino-glycine or beta-alanine useful as sweetening agents
AU6718494A (en) 2-substituted-3,4-diarylthiophene derivatives as inhibitors of cyclooxygenase
HU9702036D0 (en) New heterocyclic compounds as inhibitors of leucocita-adhesion and wla-4-antagonists
AU1694295A (en) Benzoxazinones as inhibitors of hiv reverse transcriptase
PL333918A1 (en) Derivatives of 6-phenylpyryidil-2-amine useful as nos inhibitors
PL327943A1 (en) Condensed heterocyclic derivatives of morphonoide (ii)
HU9502468D0 (en) Inhibitors of hiv reverse transcriptase
EP0707581A1 (en) Indoline derivatives as 5ht 2c? antagonists
AU3039995A (en) Heterocyclic derivatives of N-phenylamides
GB9309716D0 (en) Heterocyclic derivatives
AU5813794A (en) Aminoacid derivatives of heterocycles as protein kinase c inhibitors
PL325122A1 (en) Bicyclic derivatives of 4-aralkylamino pyrididine as inhibitors of thyrosinic kinase
HUT73670A (en) Use of indole derivatives as 5ht1 antagonists
GB9320785D0 (en) Dibenzylheterocyclic or dibenzylcycloalkyl derivatives as inhibitors of hiv intergrase
GB9408473D0 (en) Heterocyclic derivatives
AU2686388A (en) Heterocyclic derivatives of n-carbamoyl-, n-thiocarbamoyl- or n-amidino-aminomalonyl or aminosuccinyl amides useful as sweetening agents
ZA955753B (en) Heterocyclic derivatives of azolones
EP0599514A3 (en) Pyranoquinoline derivatives as inhibitors of cell proliferation.
GB9420287D0 (en) 3-substituted heterocyclic indoles as inhibitors of HIV reverse transcriptase
EP0949926A4 (en) Benzodiazepine hydrazide derivatives as inhibitors of hiv integrase

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)